Lumen Technologies (CYTH) Earnings Dates, Call Summary & Reports

Q: When does Lumen Technologies (DE:CYTH) report earnings?

Lumen Technologies (DE:CYTH) is schdueled to report earning on May 05, 2026, After Close (Confirmed).

Q: What is Lumen Technologies (DE:CYTH) earnings time?

Lumen Technologies (DE:CYTH) earnings time is at May 05, 2026, After Close (Confirmed).

Q: Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

Q: What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

Q: What is the P/E ratio of Lumen Technologies stock?

The P/E ratio of {name} is N/A.

Q: What is DE:CYTH EPS forecast?

DE:CYTH EPS forecast for the fiscal quarter 2026 (Q1) is -0.11.

Compare

9 Followers

Earnings Data

Report Date

May 05, 2026

After Close (Confirmed)

Period Ending

2026 (Q1)

Consensus EPS Forecast

-0.11

Last Year’s EPS

-0.11

Same Quarter Last Year

Analyst Consensus

Hold

Based on 8 Analysts Ratings

Earnings Call Summary

Q4 2025

Earnings Call Date:Feb 03, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call highlights a major strategic and financial pivot: closing the AT&T sale materially strengthens the balance sheet (debt reduction, lower interest expense), reduces capital intensity, and funds investments in PCF and digital/network modernization. Adoption metrics, a large prefunded PCF pipeline (~$13B) and guidance for EBITDA inflection and positive free cash flow in 2026 are encouraging. Offsetting risks include continued near-term revenue declines, a sizable YoY EBITDA drop in 2025, special charges, and the multi-year timing of PCF revenue recognition that delays some cash-to-revenue conversion. Overall, the company presents a credible path to improved margins, lower capital intensity, and stronger cash generation, while near-term operating results remain pressured.

Company Guidance

Lumen guided 2026 adjusted EBITDA of $3.1–$3.3 billion (an inflection to growth in 2026), total CapEx of $3.2–$3.4 billion (roughly $1.0 billion tied to nearly $13 billion of signed PCF deals, including ~$2.5 billion announced in Q4), and free cash flow of $1.2–$1.4 billion; net cash interest expense is expected to be $650–$750 million (about a $550 million midpoint reduction vs. 2025) and cash taxes a net inflow of $350–$450 million (including an anticipated ~$400 million tax refund in 2026). Guidance excludes roughly $400 million of multiyear transformation costs, the company targets $700 million of run-rate cost savings by year-end 2026 (having exited 2025 with >$400 million and aiming for $1.0 billion by 2027), and noted 2025 PCF revenue recognition of $116 million ($41 million in Q4). Post-close financials from the AT&T FTTx sale ($5.75 billion gross, ~$4.8 billion net proceeds) reduced debt to under $13 billion, cut net leverage to ~3.8x TTM adjusted EBITDA, and materially lowered annual interest expense (roughly $500 million year-over-year and nearly $1 billion over the last 12 months); management reiterated targets to return business revenue to growth in 2028 and total revenue in 2029.

Closing of AT&T Transaction and Balance Sheet Strengthening

Sold fiber-to-the-home business to AT&T for $5.75B (net proceeds ~$4.8B); used proceeds to pay off $4.8B super-priority bonds and reduce total debt to under $13B. Net leverage reduced by ~1.0x to ~3.8x trailing-12-month adjusted EBITDA; annual interest expense reduced roughly $500M–$1B (management cited ~45% reduction and nearly $1B lower over 12 months).

Large Prefunded Capacity-Funding (PCF) Pipeline

Signed nearly $13B of PCF deals to date (including ~$4.5B over the last 12 months and ~$2.5B in Q4). PCF deals are largely prefunded (management indicated ~90% cash upfront / ~10% on completion) and will expand network to an estimated 58 million fiber miles by 2031.

CapEx Intensity Reduction

Sale reduces annual CapEx by over $1B; full-year 2026 CapEx guidance cut to $3.2B–$3.4B from ~ $4B in the prior year. Management estimates underlying non-PCF CapEx nearer to ~$2B, representing roughly a 25% reduction in capital intensity versus 2024/2025 levels.

Improving Financial Guidance and Cash Flow Outlook

Company guides to adjusted EBITDA of $3.1B–$3.3B in 2026 (management expects an inflection to EBITDA growth in 2026) and free cash flow of $1.2B–$1.4B for 2026. Net cash interest expense guidance for 2026 is $650M–$750M (a reduction of >$550M at midpoint vs. 2025).

Cost Savings & Modernization Progress

Exceeded cost-reduction target with over $400M of run-rate savings at year-end 2025; targeting an additional $300M in 2026 to reach $700M run-rate and on track for a $1B run-rate target by 2027. Launched phase one of a new ERP to reduce systems complexity.

Product & Customer Adoption Momentum

Strong digital adoption metrics in Q4: active customers up ~29% quarter-over-quarter, services sold up ~26% QoQ, and continued NAS growth (rising ports per customer). Announced 900 off-net ports sold to date and strong IP demand within North American enterprise.

Operational Wins on Network Build and Partnerships

Reached 2025 goal of implementing 17 million intercity fiber miles; announced network upgrades (400G routes across 36 routes, metro expansion) and expanded priority fiber supply partnership with Corning to support AI backbone demand.

Debt Refinancing and Capital Structure Simplification

Completed seven refinancing transactions totaling >$11B, eliminated the second-lien layer at one level, and reduced debt tranches outstanding by ~10 (16 including super-priority paydown), materially smoothing maturities and improving financial flexibility.

Lumen Technologies (DE:CYTH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DE:CYTH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
May 05, 2026	2026 (Q1)	-0.11 / -	-0.11	―	―	―
Feb 03, 2026	2025 (Q4)	-0.22 / 0.20	0.076	155.56% (+0.12)
Oct 30, 2025	2025 (Q3)	-0.22 / -0.17	-0.11	-53.85% (-0.06)
Jul 31, 2025	2025 (Q2)	-0.22 / -0.03	-0.11	76.92% (+0.08)
May 01, 2025	2025 (Q1)	-0.22 / -0.11	-0.034	-225.00% (-0.08)
Feb 04, 2025	2024 (Q4)	-0.04 / 0.08	0.068	12.50% (<+0.01)
Nov 05, 2024	2024 (Q3)	-0.08 / -0.11	-0.076	-44.44% (-0.03)
Aug 06, 2024	2024 (Q2)	-0.04 / -0.11	0.085	-230.00% (-0.20)
Apr 30, 2024	2024 (Q1)	0.02 / -0.03	0.085	-140.00% (-0.12)
Feb 06, 2024	2023 (Q4)	-0.01 / 0.07	0.365	-81.40% (-0.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DE:CYTH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Feb 03, 2026	€7.35	€5.62	-23.59%
Oct 30, 2025	€8.88	€8.61	-3.06%
Jul 31, 2025	€3.95	€3.15	-20.26%
May 01, 2025	€3.11	€3.16	+1.58%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.